Non-Antibody Protein Therapeutics Development & Production--IBC Conference. Successful strategies for bringing protein therapeutics to market.
Thorne
Barb
B
Targeted Genetics, 1100 Olive Way, Suite 100, Seattle, WA 98101, USA. Barb.Thorne@Targen.com
D000911:Antibodies, Monoclonal; D002460:Cell Line; D016503:Drug Delivery Systems; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000379:methods*; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D040541:Marketing; D015202:Protein Engineering; D011506:Proteins / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D014612:Vaccines
D000911:Antibodies, Monoclonal; D011506:Proteins; D014612:Vaccines